Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on the results of the Ordinary and Extraordinary General Shareholders' Meetings held on April 30, 2024. The document serves as a disclosure of the final consolidated synthetic voting map for resolutions passed during these meetings, including the approval of financial statements for the fiscal year ended December 31, 2023, and amendments to the Company's Bylaws.
Key Financial Metrics
The filing text does not provide specific financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document is strictly a record of shareholder voting outcomes and corporate governance actions rather than a financial results report.
Material Changes and Voting Outcomes
The filing details the following material corporate actions approved by shareholders:
- Financial Statement Approval: Shareholders approved the managers' accounts and financial statements for the fiscal year ended December 31, 2023, with approximately 13.66 billion votes in favor.
- Profit Allocation: The allocation of net profit for 2023 and the ratification of interest on shareholders' equity were approved with approximately 14.12 billion votes in favor.
- Governance Elections: The election of the Fiscal Council was approved, including candidates proposed by minority shareholders and the Controller Slate.
- Compensation: Overall compensation for managers and Fiscal Council members for the year 2024 was approved.
- Bylaw Amendments: The Extraordinary General Meeting approved amendments to the Bylaws regarding capital increases, director independence criteria, and the restructuring of the Board of Officers.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, risk factors, or contingencies. The document is limited to the procedural reporting of voting results as required by CVM Ruling No. 81/22.
Key Facts for Investor Verification
- Verify the full text of the 2023 Annual Report to review the financial statements and profit allocation details approved in Resolution 1 and 2 of the Ordinary Meeting.
- Review the specific Bylaw amendments detailed in Exhibit B.I of the Management Proposal to understand changes to director independence and Board of Officers composition.
- Confirm the compensation structure for 2024 approved in Resolution 5, including stock option grants and share-based compensation.
- Note that this filing is a governance disclosure and does not contain operational or financial performance data for the period ending June 30, 2024.